Understanding how cells communicate and respond to their environment using advanced technology
Elucidating and Directing Heteromolecular Mechanobiology with Nanoengineered Cell Interfaces
This study is exploring how cells talk to each other and their surroundings, using cutting-edge technology to create new tools that could help us understand and improve treatments for different health conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10914781 on NIH RePORTER |
What this research studies
This research investigates the fundamental mechanisms of how cells interact with their environment and each other at a molecular level. By utilizing advanced nanotechnology and synthetic biology, the project aims to create innovative cell interfaces that can precisely manipulate and monitor cellular behavior. Patients may benefit from insights gained about cellular functions that could lead to new therapies for various conditions. The research focuses on understanding how different receptors on cells cluster and communicate, which is crucial for developing targeted treatments.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with conditions related to cellular signaling and communication, such as cancer or tissue repair issues.
Not a fit: Patients with conditions unrelated to cellular mechanisms or those who are not undergoing treatment that involves cellular interactions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in therapies that enhance cellular functions and improve treatment outcomes for various diseases.
How similar studies have performed: Other research in mechanobiology has shown promising results, indicating that understanding cellular interactions at a molecular level can lead to significant advancements in medical treatments.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Cai, Haogang — New York University School of Medicine
- Study coordinator: Cai, Haogang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.